• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    39.32 Down 0.95(2.36%) 4:00PM EDT
    |After Hours : 39.32 0.00 (0.00%) 5:09PM EDT
    Add to Portfolio
    Prev Close:40.27
    Open:39.48
    Bid:38.68 x 200
    Ask:39.64 x 100
    1y Target Est:47.55
    Beta:2.24748
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:39.01 - 40.26
    52wk Range:30.05 - 52.33
    Volume:794,501
    Avg Vol (3m):862,338
    Market Cap:4.93B
    P/E (ttm):N/A
    EPS (ttm):-0.90
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 2.36%4.93B
    IMGNDown 3.57%1.13B
    PFEDown 2.67%193.41B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.96
    Quarterly EPS Est (Sep-15) :-0.20
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-2.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback